Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. You look at survival for patients with ...

Multiple myeloma treatment has advanced with new therapies, increasing life expectancy from under 3 years to over a decade. Health disparities persist, with Black patients facing higher diagnosis ...

Your survival rate for multiple myeloma is likely higher in earlier stages. Younger people often have better outcomes due to ...

Palliative care that recognizes patient goals and values is essential, starting at diagnos ...

DVRd therapy significantly improves MRD negativity and PFS, showing potential as a frontline treatment for NDMM patients who are transplant-ineligible or deferred. The CEPHEUS trial highlights DVRd's ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Joseph Mikhael, MD ...

Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...